Abstract
Experiments were carried out to investigate the ability of rabbit anti-idiotype antibodies (Ab2), directed against an anti-human cytomegalovirus monoclonal antibody (Ab1), to induce neutralizing antibodies specific for the immunodominant glycoprotein B viral complex. Mice immunized with Ab2 produced anti-Ab2 (Ab3) that was both antigen and idiotype specific with regard to Ab1. We conclude that the Ab2 antibodies mimicked a neutralizing epitope and acted as a network antigen for inducing a specific anti-human cytomegalovirus antibody response in this experimental system.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anders E. M., Kapaklis-Deliyannis G. P., White D. O. Induction of immune response to influenza virus with anti-idiotypic antibodies. J Virol. 1989 Jun;63(6):2758–2767. doi: 10.1128/jvi.63.6.2758-2767.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Banks T., Huo B., Kousoulas K., Spaete R., Pachl C., Pereira L. A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J Gen Virol. 1989 Apr;70(Pt 4):979–985. doi: 10.1099/0022-1317-70-4-979. [DOI] [PubMed] [Google Scholar]
- Britt W. J., Vugler L. G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol. 1989 Jan;63(1):403–410. doi: 10.1128/jvi.63.1.403-410.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 1986 Nov;5(11):3057–3063. doi: 10.1002/j.1460-2075.1986.tb04606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finberg R. W., Ertl H. The use of antiidiotypic antibodies as vaccines against infectious agents. Crit Rev Immunol. 1987;7(4):269–284. [PubMed] [Google Scholar]
- Fowler K. B., Stagno S., Pass R. F., Britt W. J., Boll T. J., Alford C. A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992 Mar 5;326(10):663–667. doi: 10.1056/NEJM199203053261003. [DOI] [PubMed] [Google Scholar]
- Hiernaux J. R. Idiotypic vaccines and infectious diseases. Infect Immun. 1988 Jun;56(6):1407–1413. doi: 10.1128/iai.56.6.1407-1413.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jerne N. K., Roland J., Cazenave P. A. Recurrent idiotopes and internal images. EMBO J. 1982;1(2):243–247. doi: 10.1002/j.1460-2075.1982.tb01154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
- Kang C. Y., Nara P., Chamat S., Caralli V., Chen A., Nguyen M. L., Yoshiyama H., Morrow W. J., Ho D. D., Köhler H. Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2546–2550. doi: 10.1073/pnas.89.7.2546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kari B., Gehrz R. Biochemical and immunological analysis of discontinuous epitopes in the family of human cytomegalovirus glycoprotein complexes designated gC-I. J Gen Virol. 1991 Aug;72(Pt 8):1975–1983. doi: 10.1099/0022-1317-72-8-1975. [DOI] [PubMed] [Google Scholar]
- Keay S., Merigan T. C., Rasmussen L. Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10100–10103. doi: 10.1073/pnas.86.24.10100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keay S., Rasmussen L., Merigan T. C. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope. J Immunol. 1988 Feb 1;140(3):944–948. [PubMed] [Google Scholar]
- Köhler H., Kaveri S., Kieber-Emmons T., Morrow W. J., Müller S., Raychaudhuri S. Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol. 1989;178:3–35. doi: 10.1016/0076-6879(89)78003-4. [DOI] [PubMed] [Google Scholar]
- Köhler H., Kieber-Emmons T., Srinivasan S., Kaveri S., Morrow W. J., Müller S., Kang C. Y., Raychaudhuri S. Revised immune network concepts. Clin Immunol Immunopathol. 1989 Jul;52(1):104–116. doi: 10.1016/0090-1229(89)90197-9. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Lamarre A., Lecomte J., Talbot P. J. Antiidiotypic vaccination against murine coronavirus infection. J Immunol. 1991 Dec 15;147(12):4256–4262. [PubMed] [Google Scholar]
- Larose Y., Tackaberry E. S., Brodeur B. R. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of virus-infected cells. Hum Antibodies Hybridomas. 1991 Apr;2(2):67–73. [PubMed] [Google Scholar]
- Mariani S. M., Armandola E. A., Ferrone S. Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody. Immunology. 1992 Dec;77(4):597–603. [PMC free article] [PubMed] [Google Scholar]
- Marshall G. S., Plotkin S. A. Progress toward developing a cytomegalovirus vaccine. Infect Dis Clin North Am. 1990 Jun;4(2):283–298. [PubMed] [Google Scholar]
- Marshall G. S., Rabalais G. P., Stout G. G., Waldeyer S. L. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J Infect Dis. 1992 Feb;165(2):381–384. doi: 10.1093/infdis/165.2.381. [DOI] [PubMed] [Google Scholar]
- Nisonoff A. Idiotypes: concepts and applications. J Immunol. 1991 Oct 15;147(8):2429–2438. [PubMed] [Google Scholar]
- Palomo C., Albar J. P., García-Barreno B., Melero J. A. Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies. J Virol. 1990 Sep;64(9):4199–4206. doi: 10.1128/jvi.64.9.4199-4206.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poskitt D. C., Jean-Francois M. J., Turnbull S., Macdonald L., Yasmeen D. Internal image (Ab2 beta) anti-idiotype vaccines. Theoretical and practical aspects. Vaccine. 1991 Nov;9(11):792–796. doi: 10.1016/0264-410x(91)90215-r. [DOI] [PubMed] [Google Scholar]
- Qadri I., Navarro D., Paz P., Pereira L. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol. 1992 Nov;73(Pt 11):2913–2921. doi: 10.1099/0022-1317-73-11-2913. [DOI] [PubMed] [Google Scholar]
- Rasmussen L., Matkin C., Spaete R., Pachl C., Merigan T. C. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis. 1991 Nov;164(5):835–842. doi: 10.1093/infdis/164.5.835. [DOI] [PubMed] [Google Scholar]
- Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992 Jul 10;257(5067):238–241. doi: 10.1126/science.1352912. [DOI] [PubMed] [Google Scholar]
- Rossier E., Dimock K., Taylor D., Larose Y., Phipps P. H., Brodeur B. Sensitivity and specificity of enzyme immunofiltration and DNA hybridization for the detection of HCMV-infected cells. J Virol Methods. 1987 Feb;15(2):109–120. doi: 10.1016/0166-0934(87)90054-1. [DOI] [PubMed] [Google Scholar]
- Siber G. R., Snydman D. R. Use of immune globulins in the prevention and treatment of infections. Curr Clin Top Infect Dis. 1992;12:208–256. [PubMed] [Google Scholar]
- Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 1988 Nov;167(1):207–225. doi: 10.1016/0042-6822(88)90071-2. [DOI] [PubMed] [Google Scholar]
- Starr S. E. Cytomegalovirus vaccines: current status. Infect Agents Dis. 1992 Jun;1(3):146–148. [PubMed] [Google Scholar]
- Tackaberry E. S., Hamel J., Larose Y., Kuhl R., Brodeur B. R. Monoclonal anti-idiotypes for the rapid detection of human cytomegalovirus. J Virol Methods. 1992 Nov;40(2):175–181. doi: 10.1016/0166-0934(92)90066-m. [DOI] [PubMed] [Google Scholar]
- Utz U., Britt W., Vugler L., Mach M. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol. 1989 May;63(5):1995–2001. doi: 10.1128/jvi.63.5.1995-2001.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner B., Kropff B., Kalbacher H., Britt W., Sundqvist V. A., Ostberg L., Mach M. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. J Virol. 1992 Sep;66(9):5290–5297. doi: 10.1128/jvi.66.9.5290-5297.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiley J. A., Hamel J., Brodeur B. R. Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus 70 conformational epitopes. J Virol. 1992 Oct;66(10):5744–5751. doi: 10.1128/jvi.66.10.5744-5751.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]